{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T07:49:33Z","timestamp":1782719373924,"version":"3.54.5"},"reference-count":57,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Surg."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>The incidence of intrahepatic cholangiocarcinoma (iCCA) is increasing worldwide and remains associated with a poor prognosis. Surgical resection is the only potentially curative treatment; however, only a minority of patients are eligible due to advanced disease and vascular involvement. Irreversible electroporation (IRE) is a non-thermal ablative modality that enables tissue treatment while preserving vascular structures. This study aimed to evaluate the feasibility, safety, and preliminary oncologic outcomes of intraoperative IRE as an adjunct for margin accentuation in locally advanced iCCA involving critical vascular structures.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Between 2023 and 2024, three patients with initially unresectable, centrally located mass-forming iCCA were treated at a single center. All tumors involved the hepatic vein of the future liver remnant, precluding conventional R0 resection. Patients underwent extended hepatectomy combined with intraoperative IRE applied at the tumor\u2013hepatic vein interface, followed by vascular detachment to preserve venous outflow.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>All procedures were completed as planned. No intraoperative complications or IRE-related postoperative adverse events were observed. Ninety-day mortality was 0%. Postoperative imaging confirmed preserved hepatic vein patency in all patients. At a median follow-up of 18 months (range 15\u201327), no local recurrence at the vascular interface was detected. One patient with initially multifocal disease developed a solitary intrahepatic recurrence at 17 months, which was successfully treated with local ablation. All patients were alive at last follow-up.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Intraoperative IRE for margin accentuation appears to be a feasible and safe adjunct to extended hepatectomy in selected patients with locally advanced iCCA involving the hepatic vein of the future liver remnant. This anatomy-preserving strategy may expand surgical indications by enabling radical resection in cases otherwise deemed unresectable. Further studies are required to validate its oncologic benefit.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fsurg.2026.1835187","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T07:42:22Z","timestamp":1782718942000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Intraoperative irreversible electroporation for margin accentuation in locally advanced intrahepatic cholangiocarcinoma: a case series"],"prefix":"10.3389","volume":"13","author":[{"given":"Martin","family":"Brichard","sequence":"first","affiliation":[{"name":"Department of Surgery, CHU-UCL Namur Site Godinne","place":["Namur, Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claude","family":"Bertrand","sequence":"additional","affiliation":[{"name":"Department of Surgery, CHU-UCL Namur Site Godinne","place":["Namur, Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quentin","family":"Gilliaux","sequence":"additional","affiliation":[{"name":"Department of Oncology, CHU-UCL Namur Site Godinne","place":["Namur, Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Krug","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, CHU-UCL Namur Site Godinne","place":["Namur, Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadrien","family":"Fourneau","sequence":"additional","affiliation":[{"name":"Department of Interventional Radiology, CHU-UCL Namur Site Godinne","place":["Namur, Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claude","family":"Schalbar","sequence":"additional","affiliation":[{"name":"Department of Oncology, Centre Hospitalier du Nord","place":["Ettelbruck, Luxembourg"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Dili","sequence":"additional","affiliation":[{"name":"Department of Surgery, CHU-UCL Namur Site Godinne","place":["Namur, Belgium"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,29]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/nrgastro.2016.51","article-title":"Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European network for the study of cholangiocarcinoma (ENS-CCA)","volume":"13","author":"Banales","year":"2016","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1007\/s12029-020-00526-5","article-title":"Incidence and prognosis of biliary tract and gallbladder cancers in a Belgian academic hospital","volume":"52","author":"Gilliaux","year":"2021","journal-title":"J Gastrointest Canc"},{"key":"B3","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1634\/theoncologist.2015-0446","article-title":"Forty-Year trends in cholangiocarcinoma incidence in the U.S.: intrahepatic disease on the rise","volume":"21","author":"Saha","year":"2016","journal-title":"Oncologist"},{"key":"B4","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.jhep.2023.03.010","article-title":"EASL-ILCA Clinical practice guidelines on the management of intrahepatic cholangiocarcinoma","volume":"79","author":"Alvaro","year":"2023","journal-title":"J Hepatol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1097\/01.sla.0000251366.62632.d3","article-title":"Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution","volume":"245","author":"DeOliveira","year":"2007","journal-title":"Ann Surg"},{"key":"B6","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1093\/annonc\/mdt540","article-title":"Cisplatin and gemcitabine for advanced biliary tract cancer: a meta-analysis of two randomised trials","volume":"25","author":"Valle","year":"2014","journal-title":"Ann Oncol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1016\/j.jhep.2014.01.021","article-title":"Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma","volume":"60","author":"Bridgewater","year":"2014","journal-title":"J Hepatol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"198","DOI":"10.3322\/caac.21759","article-title":"Advances in the treatment of intrahepatic cholangiocarcinoma: an overview of the current and future therapeutic landscape for clinicians","volume":"73","author":"Moris","year":"2023","journal-title":"CA Cancer J Clin"},{"key":"B9","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1159\/000449339","article-title":"Is surgical resection justified for advanced intrahepatic cholangiocarcinoma?","volume":"5","author":"Yoh","year":"2016","journal-title":"Liver Cancer"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1016\/j.hpb.2023.06.019","article-title":"Nationwide treatment and outcomes of intrahepatic cholangiocarcinoma","volume":"25","author":"Olthof","year":"2023","journal-title":"HPB (Oxford)"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1016\/j.ejso.2020.04.007","article-title":"Outcomes of vascular resection associated with curative intent hepatectomy for intrahepatic cholangiocarcinoma","volume":"46","author":"Conci","year":"2020","journal-title":"Eur J Surg Oncol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1186\/s12876-018-0912-x","article-title":"Characterization of intrahepatic cholangiocarcinoma after curative resection: outcome, prognostic factor, and recurrence","volume":"18","author":"Chan","year":"2018","journal-title":"BMC Gastroenterol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1097\/SLA.0b013e318236c21d","article-title":"Influence of surgical margins on outcome in patients with intrahepatic cholangiocarcinoma: a multicenter study by the AFC-IHCC-2009 study group","volume":"254","author":"Farges","year":"2011","journal-title":"Ann Surg"},{"key":"B14","doi-asserted-by":"publisher","first-page":"5151","DOI":"10.3390\/cancers14205151","article-title":"R1 vascular or parenchymal margins: what is the impact after resection of intrahepatic cholangiocarcinoma?","volume":"14","author":"Mabilia","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B15","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1177\/153303460700600106","article-title":"Irreversible electroporation: a new ablation modality \u2014 clinical implications","volume":"6","author":"Rubinsky","year":"2007","journal-title":"Technol Cancer Res Treat"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.3389\/fonc.2020.01235","article-title":"Starting a fire without flame: the induction of cell death and inflammation in electroporation-based tumor ablation strategies","volume":"10","author":"Brock","year":"2020","journal-title":"Front Oncol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1352821","DOI":"10.3389\/fimmu.2024.1352821","article-title":"Irreversible electroporation promotes a pro-inflammatory tumor microenvironment and anti-tumor immunity in a mouse pancreatic cancer model","volume":"15","author":"Imran","year":"2024","journal-title":"Front Immunol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"e0166987","DOI":"10.1371\/journal.pone.0166987","article-title":"Time-Dependent impact of irreversible electroporation on pancreas, liver, blood vessels and nerves: a systematic review of experimental studies. Rakonczay Z, \u00e9diteur","volume":"11","author":"Vogel","year":"2016","journal-title":"PLoS One"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1016\/j.jvir.2024.08.021","article-title":"Irreversible electroporation in treating colorectal liver metastases in proximity to critical structures","volume":"35","author":"Narayanan","year":"","journal-title":"J Vasc Interv Radiol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.carj.2017.10.005","article-title":"Irreversible electroporation in hepatopancreaticobiliary tumours","volume":"69","author":"Ruarus","year":"2018","journal-title":"Can Assoc Radiol J"},{"key":"B21","doi-asserted-by":"publisher","first-page":"390","DOI":"10.12998\/wjcc.v8.i2.390","article-title":"Irreversible electroporation for liver metastasis from pancreatic cancer: a case report","volume":"8","author":"Ma","year":"2020","journal-title":"World J Clin Cases"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1016\/j.ejso.2021.12.015","article-title":"Irreversible electroporation for liver cancer ablation: a meta analysis","volume":"48","author":"Yu","year":"2022","journal-title":"Eur J Surg Oncol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s12032-020-01360-2","article-title":"Preliminary results in unresectable cholangiocarcinoma treated by CT percutaneous irreversible electroporation: feasibility, safety and efficacy","volume":"37","author":"Belfiore","year":"2020","journal-title":"Med Oncol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1055\/s-0039-1696649","article-title":"Ablation of intrahepatic cholangiocarcinoma","volume":"36","author":"Sweeney","year":"2019","journal-title":"Semin Intervent Radiol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1097\/SLA.0000000000001441","article-title":"Treatment of 200 locally advanced (stage III) pancreatic adenocarcinoma patients with irreversible electroporation: safety and efficacy","volume":"262","author":"Martin","year":"2015","journal-title":"Annals of Surgery."},{"key":"B26","doi-asserted-by":"publisher","first-page":"72","DOI":"10.14701\/ahbps.24-193","article-title":"Irreversible electroporation as an intraoperative adjunctive treatment for locally advanced pancreatic cancer after neoadjuvant therapy: an initial clinical experience","volume":"29","author":"Patel","year":"2025","journal-title":"Ann Hepatobiliary Pancreat Surg"},{"key":"B27","doi-asserted-by":"publisher","first-page":"3212","DOI":"10.3390\/cancers13133212","article-title":"Margin accentuation irreversible electroporation in stage III pancreatic cancer: a systematic review","volume":"13","author":"Ratnayake","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B28","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.surg.2014.06.058","article-title":"Borderline and locally advanced pancreatic adenocarcinoma margin accentuation with intraoperative irreversible electroporation","volume":"156","author":"Kwon","year":"2014","journal-title":"Surgery"},{"key":"B29","doi-asserted-by":"publisher","first-page":"5853","DOI":"10.18632\/oncotarget.14030","article-title":"Ablation of hepatic malignant tumors with irreversible electroporation: a systematic review and meta-analysis of outcomes","volume":"8","author":"Tian","year":"2017","journal-title":"Oncotarget"},{"key":"B30","doi-asserted-by":"publisher","first-page":"2384","DOI":"10.3390\/cancers15082384","article-title":"Locoregional therapy for intrahepatic cholangiocarcinoma","volume":"15","author":"Owen","year":"2023","journal-title":"Cancers (Basel)"},{"key":"B31","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.hpb.2015.08.002","article-title":"Future remnant liver function estimated by combining liver volumetry on magnetic resonance imaging with total liver function on 99mTc-mebrofenin hepatobiliary scintigraphy: can this tool predict post-hepatectomy liver failure?","volume":"18","author":"Chapelle","year":"2016","journal-title":"HPB (Oxford)"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1007\/s00270-018-1971-7","article-title":"Conductivity rise during irreversible electroporation: true permeabilization or heat?","volume":"41","author":"Ruarus","year":"2018","journal-title":"Cardiovasc Intervent Radiol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.jamcollsurg.2013.10.013","article-title":"Evaluation of resistance as a measure of successful tumor ablation during irreversible electroporation of the pancreas","volume":"218","author":"Dunki-Jacobs","year":"2014","journal-title":"J Am Coll Surg"},{"key":"B34","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","article-title":"Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey","volume":"240","author":"Dindo","year":"2004","journal-title":"Ann Surg"},{"key":"B35","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.surg.2010.10.001","article-title":"Posthepatectomy liver failure: a definition and grading by the international study group of liver surgery (ISGLS)","volume":"149","author":"Rahbari","year":"2011","journal-title":"Surgery"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/SLA.0000000000004808","article-title":"Proposal of a new comprehensive notation for hepatectomy: the \u201cnew world\u201d terminology","volume":"274","author":"Nagino","year":"2021","journal-title":"Ann Surg"},{"key":"B37","doi-asserted-by":"publisher","first-page":"2549","DOI":"10.1245\/s10434-019-07353-4","article-title":"Recurrence patterns and timing courses following curative-intent resection for intrahepatic cholangiocarcinoma","volume":"26","author":"Hu","year":"2019","journal-title":"Ann Surg Oncol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"2820","DOI":"10.3390\/jcm10132820","article-title":"Recurrence after curative resection for intrahepatic cholangiocarcinoma: how to predict the chance of repeat hepatectomy?","volume":"10","author":"Langella","year":"2021","journal-title":"J Clin Med"},{"key":"B39","doi-asserted-by":"publisher","first-page":"4363","DOI":"10.1245\/s10434-025-17038-w","article-title":"Long-Term outcomes according to surgical margin in mass-forming cholangiocarcinoma: the role of R1vasc","volume":"32","author":"Milana","year":"2025","journal-title":"Ann Surg Oncol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1053\/jlts.2001.29419","article-title":"Liver transplantation for cholangiocellular carcinoma: analysis of a single-center experience and review of the literature","volume":"7","author":"Shimoda","year":"2001","journal-title":"Liver Transpl"},{"key":"B41","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1097\/TP.0000000000003539","article-title":"Liver transplantation for intrahepatic cholangiocarcinoma: a meta-analysis and meta-regression of survival rates","volume":"105","author":"Ziogas","year":"2021","journal-title":"Transplantation"},{"key":"B42","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1245\/s10434-016-5384-z","article-title":"Aggressive hemihepatectomy combined with resection and reconstruction of middle hepatic vein for intrahepatic cholangiocarcinoma","volume":"23","author":"Miyata","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1002\/jhbp.12077","article-title":"Short- and long-term outcomes of liver resection with hepatic vein reconstruction for liver tumors: a nationwide multicenter survey","volume":"31","author":"Sadamori","year":"2024","journal-title":"J Hepato Biliary Pancreat"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1245\/s10434-015-5009-y","article-title":"Is tumor detachment from vascular structures equivalent to R0 resection in surgery for colorectal liver metastases? An observational cohort","volume":"23","author":"Vigan\u00f2","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/j.surg.2018.12.002","article-title":"Is R1 vascular hepatectomy for hepatocellular carcinoma oncologically adequate? Analysis of 327 consecutive patients","volume":"165","author":"Donadon","year":"2019","journal-title":"Surgery"},{"key":"B46","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.hpb.2019.08.015","article-title":"Oncological outcome of R1 vascular margin for mass-forming cholangiocarcinoma. A single center observational cohort analysis","volume":"22","author":"Torzilli","year":"2020","journal-title":"HPB (Oxford)"},{"key":"B47","doi-asserted-by":"publisher","first-page":"13641","DOI":"10.3389\/ti.2024.13641","article-title":"Liver transplantation for intrahepatic cholangiocarcinoma after chemotherapy and radioembolization: an intention-to-treat study","volume":"37","author":"Maspero","year":"2024","journal-title":"Transpl Int"},{"key":"B48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1056\/EVIDoa2200015","article-title":"Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer","volume":"1","author":"Oh","year":"2022","journal-title":"NEJM Evid"},{"key":"B49","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1001\/jamaoncol.2019.3702","article-title":"Radioembolization plus chemotherapy for first-line treatment of locally advanced intrahepatic cholangiocarcinoma: a phase 2 clinical trial","volume":"6","author":"Edeline","year":"2020","journal-title":"JAMA Oncol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1245\/s10434-022-12708-5","article-title":"Selective internal radiation therapy (yttrium-90 glass microspheres) combined with capecitabine in the neoadjuvant setting of operable intrahepatic CHOlangiocarcinoma: the SIROCHO trial design","volume":"30","author":"Edeline","year":"2023","journal-title":"Ann Surg Oncol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"101279","DOI":"10.1016\/j.jhepr.2024.101279","article-title":"First-line chemotherapy with selective internal radiation therapy for intrahepatic cholangiocarcinoma: the French ACABi GERCOR PRONOBIL cohort","volume":"7","author":"Adamus","year":"2025","journal-title":"JHEP Reports"},{"key":"B52","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.hpb.2015.07.002","article-title":"A systematic review of contralateral liver lobe hypertrophy after unilobar selective internal radiation therapy with Y90","volume":"18","author":"Teo","year":"2016","journal-title":"HPB (Oxford)"},{"key":"B53","doi-asserted-by":"publisher","first-page":"4754","DOI":"10.3390\/curroncol30050358","article-title":"The potential role of adjuvant chemoradiotherapy in patients with microscopically positive (R1) surgical margins after resection of cholangiocarcinoma","volume":"30","author":"Palloni","year":"2023","journal-title":"Current Oncology"},{"key":"B54","doi-asserted-by":"publisher","first-page":"3037","DOI":"10.3748\/wjg.v27.i22.3037","article-title":"Role of imaging in evaluating the response after neoadjuvant treatment for pancreatic ductal adenocarcinoma","volume":"27","author":"Zhang","year":"2021","journal-title":"World J Gastroenterol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.surg.2022.07.033","article-title":"Impact of margin accentuation with intraoperative irreversible electroporation on local recurrence in resected pancreatic cancer","volume":"173","author":"Martin","year":"2023","journal-title":"Surgery"},{"key":"B56","doi-asserted-by":"publisher","first-page":"W62","DOI":"10.2214\/AJR.11.6940","article-title":"Characterization of irreversible electroporation ablation in in vivo porcine liver","volume":"198","author":"Ben-David","year":"2012","journal-title":"Am J Roentgenol"},{"key":"B57","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1148\/radiol.13130349","article-title":"Irreversible electroporation ablation: creation of large-volume ablation zones in in vivo porcine liver with four-electrode arrays","volume":"270","author":"Appelbaum","year":"2014","journal-title":"Radiology"}],"container-title":["Frontiers in Surgery"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fsurg.2026.1835187\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T07:42:23Z","timestamp":1782718943000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fsurg.2026.1835187\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,29]]},"references-count":57,"alternative-id":["10.3389\/fsurg.2026.1835187"],"URL":"https:\/\/doi.org\/10.3389\/fsurg.2026.1835187","relation":{},"ISSN":["2296-875X"],"issn-type":[{"value":"2296-875X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,29]]},"article-number":"1835187"}}